Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8252958
APP PUB NO 20090306430A1
SERIAL NO

12085588

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns the use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells, said derivatives corresponding to formula (I), wherein: R═H or C1 and the phenyl group comprises two substituents, or a pharmaceutically acceptable salt of said derivatives.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)3 RUE MICHEL ANGE PARIS 75016
UNIVERSITE DE POITIERS15 RUE DE L'HÔTEL DIEU POITIERS F-86000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Becq, Frederic Poitiers, FR 8 29
Blondel, Marc Saint-Pol de Leon, FR 10 18
Triboullard, Deborah Roscoff, FR 1 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation